Paradigm Biopharmaceuticals Limited

PAR.AX·ASX·Healthcare
Compare
0.24500.0000 (0.00%)today
At close: Sep 18, 5:10 PM AEDT · May be delayed up to 20 min · AUD

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.2450
Open0.2550
Day range0.24500.2650
52-week range0.13500.4700
Off day high−7.55%
Off 52-week high−47.87%
Volume3.14M
Avg. volume (3M)1.66M
Market cap153.48M
EPS (TTM)-0.1500
Forward P/E1.35
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.03
Shares outstanding626.43M
Short interest—
Earnings dateJul 29, 2025 (est.)
Analyst target1.0800
Profit margin0.00%

Against its peers

Compare in full ›
PAR.AX ZNTL LXRX ZLAB ZBIO ZYME
Market cap 153.48M 216.85M 631.84M 2.70B 1.75B 2.02B
P/E (TTM) — — — — — —
Forward P/E 1.3 -1.3 -7.5 -11.4 -5.8 31.3
Price/book 40.8 1.1 3.6 4.4 6.9 25.1
Dividend yield — — — — — —
1-year change −43.68% +40.94% +4.93% −8.77% +18.14% +60.32%
Today 0.00% −8.30% −4.70% +9.03% −4.82% −0.77%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All PAR.AX news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

In the news

2mentions in 30 days
2with it in the headline
Negativesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.